The Latest in Critical Care, 9/28/23 (Issue #15)
PulmCCM
SEPTEMBER 28, 2023
with Covid-19 randomized to 800 μg of inhaled budesonide twice daily had significantly fewer urgent care visits, and faster resolution of symptoms. Those receiving budesonide reported feeling better three days sooner than patients in the usual-care arm.
Let's personalize your content